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Background
Left ventricular ejection fraction (LVEF) is the most vali-
dated independent prognostic factor for mortality, ventri-
cular arrhythmias and heart failure (HF) in non-ischemic
dilated cardiomyopathy without etiology. However, mild
or moderate reduction LVEF yield limited predictive value.
The amount of fibrosis, detected by late gadolinium
enhancement (LGE) on CMR, has also been validated as
an independent predictor factor.
Conventional imaging techniques cannot robustly quan-
tify the full spectrum of extracellular cardiac matrix
volume (ECV) expansion. ECV expansion often may not
be evident on LGE CMR or other modalities.
Quantifying ECV may ultimately provide independent
prognostic value to improve care through targeted
treatment.
The aim of this study was to determine the prognostic
value of myocardial ECV expansion in patients with non-
ischemic cardiomyopathy.
Methods
Patients clinically referred for cardiac MRI evaluation
between December 2008 and January 2014 with non-
ischemic cardiomyopathy with LVEF<60% were included
in the study cohort. Primary endpoints included death and
heart failure (HF) admissions. Elevated ECV was based on
2SD above normal volunteers sampling, at a cutoff of 34%.
T1 measurements were performed with a cine Look-
Locker sequence non-slice-selective inversion pulse,
followed by segmented gradient-echo acquisition for 17
cardiac phases after inversion, spread over 2 cardiac cycles.
Results
Three hundred and fifty nine patients were included. The
mean age was 50 +/- 16 years; 60% were male; LV EF was
46 +/- 10%; LV end diastole and end systole volume index
(mL/m2) were 98+ 34 and 56+34, respectively. Mean LV
mass was 60+/-21 g. At a median follow-up of 2.5 yrs
(IQR 2.5 yrs), 22 deaths and 24 HF admissions resulted.
LGE was positive in 32% of patients. Depressed LV EF
under 30% was present in 15% of the population. Twenty
five percent of patients had an ECV mean over 34%.
Adjusted for LV EF <30% and LGE presence, elevated
ECV showed a significant association with death (p=0.009;
HR=3.83;CI=1.39-10.51).
Conclusions
1. ECV provides prognostic value for mortality of
patients with non-ischemic CMP, incremental to LVEF
and presence of myocardial scar by CMR.
2. Adjusted to LVEF of <30% and LGE presence, ECV
mean > 34% portends to a near 4-fold increased risk for
death.
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Figure 1 Plots of Kaplan-Meier product limit estimates of survival based on ECV and LVEF.
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